Cargando…

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer’s Disease Pathology

Alzheimer’s disease (AD) is characterized by a long pre-clinical phase (20–30 years), during which significant brain pathology manifests itself. Disease mechanisms associated with pathological hallmarks remain elusive. Most processes associated with AD pathogenesis, such as inflammation, synaptic dy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenberger, Andrea F.N., Hilhorst, Riet, Coart, Elisabeth, García Barrado, Leandro, Naji, Faris, Rozemuller, Annemieke J.M., van der Flier, Wiesje M., Scheltens, Philip, Hoozemans, Jeroen J.M., van der Vies, Saskia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927853/ https://www.ncbi.nlm.nih.gov/pubmed/26519433 http://dx.doi.org/10.3233/JAD-150429

Ejemplares similares

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology
por: Rosenberger, Andrea FN, et al.
Publicado: (2014)

Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology
por: Rosenberger, Andrea F. N., et al.
Publicado: (2016)

Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease
por: Hoozemans, Jeroen JM, et al.
Publicado: (2005)

Neuroinflammation in Alzheimer's disease wanes with age
por: Hoozemans, Jeroen JM, et al.
Publicado: (2011)

Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease
por: Eikelenboom, Piet, et al.
Publicado: (2012)

Amsterdam Dementia Cohort: Performing Research to Optimize Care
por: van der Flier, Wiesje M., et al.
Publicado: (2018)

Braiding Braak and Braak: Staging patterns and model selection in network neurodegeneration
por: Putra, Prama, et al.
Publicado: (2021)

Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease
por: Pelkmans, Wiesje, et al.
Publicado: (2019)

Exploring Braak’s Hypothesis of Parkinson’s Disease
por: Rietdijk, Carmen D., et al.
Publicado: (2017)

Hypertensive Disorders of Pregnancy Appear Not to Be Associated with Alzheimer's Disease Later in Life
por: Abheiden, Carolien N.H., et al.
Publicado: (2015)

The prion hypothesis in Parkinson's disease: Braak to the future
por: Visanji, Naomi P, et al.
Publicado: (2013)

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

Longitudinal atrophy in early Braak regions in preclinical Alzheimer's disease
por: Xie, Long, et al.
Publicado: (2020)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Neuroinflammation is increased in the parietal cortex of atypical Alzheimer’s disease
por: Boon, Baayla D. C., et al.
Publicado: (2018)

Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition
por: Dicks, Ellen, et al.
Publicado: (2020)

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease
por: Chatterjee, Madhurima, et al.
Publicado: (2018)

Microglia activation in sepsis: a case-control study
por: Lemstra, Afina W, et al.
Publicado: (2007)

Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline
por: Pelkmans, Wiesje, et al.
Publicado: (2022)

Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer’s Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity
por: Louwersheimer, Eva, et al.
Publicado: (2017)

Clinical outcomes up to 9 years after [(18)F]flutemetamol amyloid-PET in a symptomatic memory clinic population
por: Collij, Lyduine E., et al.
Publicado: (2023)

The Free and Cued Selective Reminding Test Predicts Braak Stage
por: Grober, Ellen, et al.
Publicado: (2021)

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes
por: Pijnenburg, Yolande A.L., et al.
Publicado: (2015)

The aged rhesus macaque manifests Braak stage III/IV Alzheimer’s-like pathology
por: Paspalas, Constantinos D., et al.
Publicado: (2017)

The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series
por: Ulugut Erkoyun, Hulya, et al.
Publicado: (2021)

Exercise and Early-Onset Alzheimer's Disease: Theoretical Considerations
por: Hooghiemstra, Astrid M., et al.
Publicado: (2012)

Neuropathology and cognitive performance in self-reported cognitively healthy centenarians
por: Ganz, Andrea B., et al.
Publicado: (2018)

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease
por: Dicks, Ellen, et al.
Publicado: (2019)

Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
por: Jutten, Roos J., et al.
Publicado: (2021)

Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer’s Disease. An MEG Study with Virtual Electrodes
por: Engels, Marjolein M. A., et al.
Publicado: (2016)

Braak neurofibrillary tangle staging prediction from in vivo MRI metrics
por: Dallaire-Théroux, Caroline, et al.
Publicado: (2019)

Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
por: Therriault, Joseph, et al.
Publicado: (2022)

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
por: Engels, Marjolein MA, et al.
Publicado: (2015)

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics
por: den Haan, Jurre, et al.
Publicado: (2018)

Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
por: Wiersma, Vera I., et al.
Publicado: (2016)

Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory
por: de Haan, Willem, et al.
Publicado: (2009)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Neuropsychiatric symptoms in patients with possible vascular cognitive impairment, does sex matter?
por: Exalto, LG, et al.
Publicado: (2022)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oroi82pk353ng7frptib6b1t5j